|
DE2947526A1
(de)
|
1978-11-29 |
1980-06-12 |
Ono Pharmaceutical Co |
Prostacyclin-analoge
|
|
US4668814A
(en)
|
1984-03-08 |
1987-05-26 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
JPS61289034A
(ja)
|
1985-06-17 |
1986-12-19 |
Teijin Ltd |
イソカルバサイクリン類脂肪乳剤
|
|
US4837342A
(en)
|
1986-02-28 |
1989-06-06 |
Sagami Chemical Research Center |
Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient
|
|
GB8814438D0
(en)
|
1988-06-17 |
1988-07-20 |
Wellcome Found |
Compounds for use in medicine
|
|
GB9011588D0
(en)
|
1990-05-24 |
1990-07-11 |
Wellcome Found |
Prostaglandin analogues for use in medicine
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
CA2056039A1
(en)
|
1991-01-22 |
1992-07-23 |
Philip L. Fuchs |
Carbacyclin analogs
|
|
US5190972A
(en)
|
1992-01-27 |
1993-03-02 |
The University Of Melbourne |
Method of combatting cyclosporine organ toxicity with prostaglandin analogs
|
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
|
US6638621B2
(en)
|
2000-08-16 |
2003-10-28 |
Lyotropic Therapeutics, Inc. |
Coated particles, methods of making and using
|
|
US6441245B1
(en)
|
1997-10-24 |
2002-08-27 |
United Therapeutics Corporation |
Process for stereoselective synthesis of prostacyclin derivatives
|
|
EP1045695B1
(en)
|
1997-11-14 |
2004-03-24 |
United Therapeutics Corporation |
Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease
|
|
EP1043031A4
(en)
|
1997-12-26 |
2007-05-02 |
Astellas Pharma Inc |
MEDICINAL COMPOSITIONS WITH PROLONGED RELEASE
|
|
JP2002521423A
(ja)
|
1998-07-31 |
2002-07-16 |
コリア インスティチュート オブ サイエンス アンド テクノロージ |
遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子
|
|
US6265495B1
(en)
|
1998-09-22 |
2001-07-24 |
Nippon Shokubai Co., Ltd. |
Method for production of esterified product
|
|
US6521212B1
(en)
|
1999-03-18 |
2003-02-18 |
United Therapeutics Corporation |
Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
|
|
CN1354622A
(zh)
|
1999-03-31 |
2002-06-19 |
联合治疗公司 |
前列腺素类化合物、组合物和治疗外周血管疾病和肺动脉高压的方法
|
|
US6242482B1
(en)
|
2000-06-05 |
2001-06-05 |
United Therapeutics Corporation |
Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
|
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
|
US6991809B2
(en)
|
2001-06-23 |
2006-01-31 |
Lyotropic Therapeutics, Inc. |
Particles with improved solubilization capacity
|
|
US20030108512A1
(en)
|
2001-12-10 |
2003-06-12 |
Robert Shorr |
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
|
|
US6803386B2
(en)
|
2002-01-16 |
2004-10-12 |
United Therapeutics Corporation |
Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
|
|
US20040156816A1
(en)
|
2002-08-06 |
2004-08-12 |
David Anderson |
Lipid-drug complexes in reversed liquid and liquid crystalline phases
|
|
MXPA05012467A
(es)
|
2003-05-19 |
2006-02-22 |
Baxter Int |
Particulas solidas que comprenden un anticonvulsivo o un inmunosupresor revestido con uno o mas modificadores de superficie.
|
|
ES2272914T3
(es)
|
2003-05-20 |
2007-05-01 |
Ethypharm |
Composicion farmaceutica oral de liberacion sostenida.
|
|
CN101265226B
(zh)
|
2003-05-22 |
2013-04-24 |
联合治疗公司 |
化合物和释放前列环素类似物的方法
|
|
CN1917866B
(zh)
|
2003-12-16 |
2010-12-15 |
联合治疗公司 |
曲前列环素或它的衍生物，或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途
|
|
CA2549801C
(en)
|
2003-12-16 |
2012-10-16 |
United Therapeutics Corporation |
Use of treprostinil to improve kidney functions
|
|
ATE462427T1
(de)
|
2004-04-12 |
2010-04-15 |
United Therapeutics Corp |
Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
|
|
GB0416328D0
(en)
|
2004-07-21 |
2004-08-25 |
Univ Cardiff |
Use of dry powder compositions for pulmonary delivery
|
|
MX2007000979A
(es)
|
2004-07-26 |
2007-07-11 |
Cotherix Inc |
Tratamiento de la hipertension pulmonar por iloprost inhalado con una formulacion microparticulada.
|
|
JP4893999B2
(ja)
|
2004-10-22 |
2012-03-07 |
小野薬品工業株式会社 |
吸入用医薬組成物
|
|
WO2007070851A2
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
CN101495122B
(zh)
|
2006-05-15 |
2011-10-05 |
联合治疗公司 |
使用定量吸入器给予曲前列尼
|
|
US20090036465A1
(en)
|
2006-10-18 |
2009-02-05 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
CA2678258A1
(en)
|
2007-02-09 |
2008-08-14 |
United Therapeutics Corporation |
Treprostinil treatment for interstitial lung disease and asthma
|
|
WO2008124632A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
|
CA2698721A1
(en)
|
2007-09-07 |
2009-03-12 |
United Therapeutics Corporation |
Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
|
|
KR20160048222A
(ko)
|
2007-12-17 |
2016-05-03 |
유나이티드 세러퓨틱스 코오포레이션 |
레모둘린?의 활성 성분인 트레프로스티닐의 개선된 제조 방법
|
|
US8350079B2
(en)
|
2008-05-08 |
2013-01-08 |
United Therapeutics Corporation |
Treprostinil formulation
|
|
WO2009152160A1
(en)
|
2008-06-10 |
2009-12-17 |
Gilead Sciences, Inc. |
Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
|
|
US20110294815A1
(en)
|
2008-06-27 |
2011-12-01 |
Harbeson Scott L |
Prostacyclin analogs
|
|
WO2010039531A1
(en)
|
2008-09-23 |
2010-04-08 |
Resolvyx Pharmaceuticals, Inc. |
Therapeutic compounds
|
|
KR20110081204A
(ko)
|
2008-09-25 |
2011-07-13 |
아라다임 코포레이션 |
트레프로스티닐의 폐 심부 전달
|
|
CA2749352A1
(en)
|
2009-02-20 |
2010-09-10 |
Micro Labs Limited |
Storage stable prostaglandin product
|
|
JP5649645B2
(ja)
|
2009-05-07 |
2015-01-07 |
ユナイテッド セラピューティクス コーポレイション |
プロスタサイクリンアナログの固形製剤
|
|
JP6087147B2
(ja)
|
2009-06-22 |
2017-03-01 |
ジョンソン、マッセイ、パブリック、リミテッド、カンパニーＪｏｈｎｓｏｎ Ｍａｔｔｈｅｙ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ |
プロスタグランジンの精製方法
|
|
US20120270934A1
(en)
|
2009-07-03 |
2012-10-25 |
Concert Pharmaceuticals, Inc. |
Prostacyclin derivatives
|
|
RS53234B
(sr)
|
2009-08-07 |
2014-08-29 |
Scipharm Sàrl |
Kompozicija za lečenje cistične fibroze
|
|
BR112012003834A2
(pt)
|
2009-08-21 |
2017-08-08 |
Targeted Delivery Tech Limited |
métodos para tratamento de distúrbios e para tratamentos de deficiências em ácidos graxos, hipertrigliceridemia ou hipercolesterolemia e pacote
|
|
CN101669904B
(zh)
|
2009-09-29 |
2011-06-22 |
北京中海康医药科技发展有限公司 |
一种依前列醇脂质纳米粒及制备方法
|
|
WO2011089215A1
(en)
|
2010-01-22 |
2011-07-28 |
Ascendis Pharma As |
Dipeptide-based prodrug linkers for aromatic amine-containing drugs
|
|
EP2525830B1
(en)
|
2010-01-22 |
2016-05-11 |
Ascendis Pharma A/S |
Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
|
|
EP3108888B1
(en)
|
2010-03-15 |
2020-02-12 |
United Therapeutics Corporation |
Treatment for pulmonary hypertension
|
|
WO2011153363A1
(en)
|
2010-06-03 |
2011-12-08 |
United Therapeutics Corporation |
Treprostinil production
|
|
WO2011159693A2
(en)
|
2010-06-15 |
2011-12-22 |
United Therapeutics Corporation |
Oral treatment of digital ischemic lesions
|
|
WO2012006273A1
(en)
|
2010-07-09 |
2012-01-12 |
United Therapeutics Corporation |
Combination therapies with cox-2 inhibitors and treprostinil
|
|
CA2710726C
(en)
|
2010-07-22 |
2016-02-23 |
Alphora Research Inc. |
Synthesis of treprostinil and intermediates useful therein
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
JP5780775B2
(ja)
|
2011-02-18 |
2015-09-16 |
株式会社Ｌｔｔバイオファーマ |
プロスタグランジンｉ２誘導体を含有するナノ粒子
|
|
EP2681204B1
(en)
|
2011-03-02 |
2016-04-27 |
United Therapeutics Corporation |
Synthesis of intermediate for treprostinil production
|
|
CN103561725B
(zh)
|
2011-03-14 |
2018-08-31 |
国立大学法人北海道大学 |
用于肺递送的载体、导入剂及用途
|
|
WO2013024047A1
(en)
|
2011-08-12 |
2013-02-21 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
|
HK1198913A1
(en)
|
2011-08-12 |
2015-06-19 |
Ascendis Pharma A/S |
Carrier-linked prodrugs having reversible carboxylic ester linkages
|
|
HK1198358A1
(en)
|
2011-08-12 |
2015-04-10 |
Ascendis Pharma A/S |
Sustained release composition of prostacyclin
|
|
AU2012296951B2
(en)
|
2011-08-12 |
2016-09-15 |
Ascendis Pharma A/S |
Protein carrier-linked prodrugs
|
|
AU2012296950B2
(en)
|
2011-08-12 |
2016-09-22 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
|
MX349950B
(es)
|
2011-08-12 |
2017-08-22 |
Ascendis Pharma As |
Profarmacos de treprostinil enlazados a un portador.
|
|
US8524939B2
(en)
|
2011-08-24 |
2013-09-03 |
Chirogate International Inc. |
Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
|
|
US9387214B2
(en)
|
2012-01-13 |
2016-07-12 |
United Therapeutics Corporation |
Method of identifying therapies for pulmonary hypertension
|
|
PL2674413T3
(pl)
|
2012-06-15 |
2018-05-30 |
Scipharm Sàrl |
Sposób wytwarzania treprostynilu i jego pochodnych
|
|
ES2869701T3
(es)
|
2012-08-01 |
2021-10-25 |
United Therapeutics Corp |
Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
|
|
CA2880808C
(en)
|
2012-08-01 |
2023-01-24 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
|
AU2013351934B2
(en)
|
2012-11-30 |
2018-03-29 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
JP6431850B2
(ja)
|
2013-01-09 |
2018-11-28 |
ユナイテッド セラピューティクス コーポレイション |
プロスタサイクリンおよび間葉系幹細胞による脈管障害の処置
|
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
EP3712142B1
(en)
|
2013-01-11 |
2022-07-06 |
Corsair Pharma, Inc. |
Prodrugs of treprostinil
|
|
EP2970091A4
(en)
|
2013-03-14 |
2017-02-08 |
United Therapeutics Corporation |
Solid forms of treprostinil
|
|
US20140275616A1
(en)
|
2013-03-15 |
2014-09-18 |
United Therapeutics Corporation |
Salts of treprostinil
|
|
EP2978313B1
(en)
|
2013-03-25 |
2018-02-21 |
United Therapeutics Corporation |
Process of making prostacyclin compounds with linker thiol and pegylated forms
|
|
CN105407883A
(zh)
|
2013-04-30 |
2016-03-16 |
联合治疗学有限公司 |
控释药物制剂
|
|
WO2014203278A2
(en)
|
2013-06-19 |
2014-12-24 |
Msn Laboratories Private Limited |
NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
|
|
US9925184B2
(en)
|
2013-10-11 |
2018-03-27 |
Pulmokine, Inc. |
Spray-dry formulations
|
|
LT3060041T
(lt)
*
|
2013-10-25 |
2021-03-25 |
Insmed Incorporated |
Prostaciklino junginiai
|
|
WO2015138423A1
(en)
|
2014-03-11 |
2015-09-17 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
CN106573066A
(zh)
|
2014-06-13 |
2017-04-19 |
联合治疗学有限公司 |
曲前列环素制剂
|
|
ES2778274T3
(es)
|
2014-10-20 |
2020-08-10 |
United Therapeutics Corp |
Síntesis de productos intermedios para producir derivados de prostaciclina
|
|
JP6866043B2
(ja)
|
2014-11-18 |
2021-04-28 |
インスメッド インコーポレイテッド |
トレプロスチニルプロドラッグおよびトレプロスチニル誘導体プロドラッグの製造方法
|
|
WO2016176555A1
(en)
|
2015-04-29 |
2016-11-03 |
Insmed Incorporated |
Prostacyclin compounds, compositions and methods of use thereof
|
|
US10898494B2
(en)
|
2016-05-05 |
2021-01-26 |
Liquidia Technologies, Inc. |
Dry powder treprostinil for the treatment of pulmonary hypertension
|
|
WO2017223400A1
(en)
|
2016-06-24 |
2017-12-28 |
Insmed Incorporated |
Prostacyclin compounds and compositions for treating sarcoidosis
|
|
JP7220650B2
(ja)
|
2016-09-26 |
2023-02-10 |
ユナイテッド セラピューティクス コーポレイション |
トレプロスチニルプロドラッグ
|
|
EP3673895A1
(en)
|
2018-12-28 |
2020-07-01 |
Université Libre de Bruxelles |
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
|
|
JP7455144B2
(ja)
|
2019-04-29 |
2024-03-25 |
インスメッド インコーポレイテッド |
トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法
|